Results 1 to 10 of about 266 (79)

Japanese guidelines for allergic conjunctival diseases 2020

Allergology International, 2020
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease 2019 ...
Dai Miyazaki, Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, Shigeaki Ohno, Yuichi Ohashi, Shigeki Okamoto, Yoshiyuki Satake, Jun Shoji, Kenichi Namba, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima   +12 more
doaj   +1 more source

Japanese Guideline for Allergic Conjunctival Diseases

Allergology International, 2011
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second ...
Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, Shigeaki Ohno, Yuichi Ohashi, Shigeki Okamoto, Naoki Kumagai, Yoshiyuki Satake, Jun Shoji, Yayoi Nakagawa, Kenichi Namba, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima   +13 more
doaj   +1 more source

Japanese guidelines for allergic conjunctival diseases 2017

Allergology International, 2017
The definition, classification, pathogenesis, test methods, clinical findings, criteria for diagnosis, and therapies of allergic conjunctival disease are summarized based on the Guidelines for Clinical Management of Allergic Conjunctival Disease (Second ...
Etsuko Takamura, Eiichi Uchio, Nobuyuki Ebihara, Shigeaki Ohno, Yuichi Ohashi, Shigeki Okamoto, Naoki Kumagai, Yoshiyuki Satake, Jun Shoji, Yayoi Nakagawa, Kenichi Namba, Kazumi Fukagawa, Atsuki Fukushima, Hiroshi Fujishima   +13 more
doaj   +1 more source

Anti-inflammatory and Antihistaminic Study of a Unani Eye Drop Formulation

Ophthalmology and Eye Diseases, 2010
The Unani eye drop is an ophthalmic formulation prepared for its beneficial effects in the inflammatory and allergic conditions of the eyes. In the present study, the Unani eye drop formulation was prepared and investigated for its anti-inflammatory and ...
Latif Abdul, Razique Abdul, R.R. Sukul, Siddiqui Nazish   +3 more
doaj   +1 more source

Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.

Molecular vision, 2011
To compare the effects of benzalkonium chloride (BAC)-preserved and unpreserved antiallergic eye drops on the human 3D-reconstituted corneal epithelial model (3D-HCE).3D-HCE were treated for 24 h followed or not by a 24 h post-incubation recovery period (24 h+24 h) with phosphate-buffered saline (PBS), 0.01% BAC, unpreserved formulations of ketotifen ...
Pauly, A., Brasnu, E, Riancho, L, Brignole-Baudouin, F, Baudouin, C.   +4 more
openaire   +2 more sources

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis. [PDF]

Clin Ophthalmol, 2023
Marini MC, Berra ML, Girado F, Albera PA, Del Papa MS, Passerini MS, Aguilar AJ.   +6 more
europepmc   +1 more source

Effectiveness of a modified therapeutic protocol for the management of vernal keratoconjunctivitis based on Bonini's graded clinical severity. [PDF]

Indian J Ophthalmol, 2022
Pradhan A, Pattanayak S, Dora J, Subudhi P.   +3 more
europepmc   +1 more source

Knowledge, Attitudes, and Practices Toward Self-Medicating Eye Symptoms in Saudi Arabia. [PDF]

Clin Ophthalmol, 2022
Alessa DI, AlHuthail RR, Al Mahfud SA, Alshngeetee AS, Alruwaili SA, Khalaf AM, Almutlq MM.   +6 more
europepmc   +1 more source

Allergen challenge tests in allergen immunotherapy: State of the art. [PDF]

Allergol Select, 2023
Zieglmayer P, Zieglmayer R, Lemell P.
europepmc   +1 more source

Case Report: Corneal Inlay Removal after Myofibroblast Detection under in Vivo Confocal Microscopy. [PDF]

Optom Vis Sci, 2023
Yoshitomi S, Chikama T, Kiuchi Y.
europepmc   +1 more source